Literature DB >> 22923180

Characteristics and outcome of Goodpasture's disease in children.

Allan Bayat1, Konstantinos Kamperis, Troels Herlin.   

Abstract

Antiglomerular basement membrane antibody disease (aGD) remains a very uncommon entity in the pediatric population, characterized by pulmonary hemorrhage, glomerulonephritis, and antibodies against the glomerular basement membrane. We herein describe the case of a 14-year-old girl with primary pulmonary symptoms diagnosed with aGD. Furthermore, we review 23 cases described in English literature over a 25-year period. Our case is the fourth child that presented with only pulmonary symptoms and no or minimal renal involvement. Based on the 23 cases, we present data on demographics and clinical symptoms, diagnostic tools, and prognosis. aGD presents in children with a male/female ratio of 1:2. Most children (91 %) survive, but in many cases renal disease progresses to end stage, requiring maintenance therapy on dialysis and some undergo kidney transplantation. However, no case was identified with signs of relapse after remission. aGD should be considered in the differential diagnosis of diffuse lung hemorrhage despite the lack of renal abnormalities. Antiglomerular basement membrane antibody testing can be of great value in confirming the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923180     DOI: 10.1007/s10067-012-2062-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  46 in total

1.  Successful management of anti-GBM disease in a 5 1/2-year-old girl.

Authors:  Sevcan Azime Bakkaloglu; Cigdem Seher Kasapkara; Oguz Soylemezoglu; Harun Peru; Kibriya Fidan; Enver Hasanoglu; Necla Buyan
Journal:  Nephrol Dial Transplant       Date:  2006-07-12       Impact factor: 5.992

2.  Anti-GBM antibodies co-exist with MPO-ANCA in a 4-year-old girl with acute renal failure.

Authors:  Sarveshni Naidoo; Simon Waller
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

Review 3.  Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

Authors:  Paul A Monach; Lindsay M Arnold; Peter A Merkel
Journal:  Arthritis Rheum       Date:  2010-01

4.  Chronic recurrent Goodpasture's syndrome.

Authors:  P S Mehler; M W Brunvand; M P Hutt; R J Anderson
Journal:  Am J Med       Date:  1987-04       Impact factor: 4.965

5.  Changes in glomerular basement membrane antigen(s) with age.

Authors:  S K Anand; B H Landing; E T Heuser; D L Olson; C M Grushkin; E Lieberman
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

6.  Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes.

Authors:  M Fisher; C D Pusey; R W Vaughan; A J Rees
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

7.  Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Authors:  J B Levy; A N Turner; A J Rees; C D Pusey
Journal:  Ann Intern Med       Date:  2001-06-05       Impact factor: 25.391

8.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

9.  Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases.

Authors:  F Merkel; O Pullig; M Marx; K O Netzer; M Weber
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

10.  Isolated pulmonary Goodpasture syndrome.

Authors:  P Harrity; E Gilbert-Barness; A Cabalka; R Hong; J Zimmerman
Journal:  Pediatr Pathol       Date:  1991 Jul-Aug
View more
  9 in total

Review 1.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

2.  Maternal alloimmune IgG causes anti-glomerular basement membrane disease in perinatal transgenic mice that express human laminin α5.

Authors:  Dale R Abrahamson; Brooke M Steenhard; Larysa Stroganova; Adrian Zelenchuk; Patricia L St John; Margaret G Petroff; Manuel Patarroyo; Dorin Bogdan Borza
Journal:  Kidney Int       Date:  2019-07-10       Impact factor: 10.612

3.  A unique way to treat Goodpasture's disease.

Authors:  Maya Narayanan; Isabel Casimiro; Raimund Pichler
Journal:  BMJ Case Rep       Date:  2014-11-24

4.  Management and outcomes of childhood Goodpasture's disease.

Authors:  Carmela P Menzi; Barbara S Bucher; Mario G Bianchetti; Gianluigi Ardissino; Giacomo D Simonetti
Journal:  Pediatr Res       Date:  2018-01-10       Impact factor: 3.756

5.  Anti-GBM disease after nephrectomy for xanthogranulomatous pyelonephritis in a patient expressing HLA DR15 major histocompatibility antigens: a case report.

Authors:  Emma O'Hagan; Tamara Mallett; Mairead Convery; Karl McKeever
Journal:  Clin Nephrol Case Stud       Date:  2015-11-02

Review 6.  Anti-glomerular basement membrane disease in children: a brief overview.

Authors:  Thomas Dowsett; Louise Oni
Journal:  Pediatr Nephrol       Date:  2021-11-12       Impact factor: 3.651

Review 7.  Idiopathic Pulmonary Hemosiderosis as a Mimic of Pulmonary Vasculitis: A Case Report and Review of the Literature.

Authors:  Mary Buckley; Heather Van Mater
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.919

8.  Case report: anti-glomerular basement membrane antibody disease with normal renal function.

Authors:  China Nagano; Yoshimitu Goto; Katuaki Kasahara; Yoshiyuki Kuroyanagi
Journal:  BMC Nephrol       Date:  2015-11-04       Impact factor: 2.388

9.  Atypical Antiglomerular Basement Membrane Disease in a Pediatric Patient Successfully Treated with Rituximab.

Authors:  Kuang-Yu Jen; Ari Auron
Journal:  Case Rep Nephrol       Date:  2021-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.